| May 31,
2014 | May 31,
2020 | May 31,
2021 | May 31,
2023 |
|---|
| NET INCOME (LOSS) | -643,763 | -944,813 | -2,824,725 | 1 |
|---|
| Depreciation of music inventory | - | 3,564 | 3,096 | - |
|---|
| Income (expense) from derivative liability | - | -647,927 | -36,930 | - |
|---|
| Amortization of debt discounts | - | 546,399 | 473,080 | - |
|---|
| Loss on conversion of notes payable and accrued interest | - | 159,802 | 1 | - |
|---|
| Depreciation of music inventory | - | - | - | 1,238 |
|---|
| Income (expense) from derivative liability | - | - | - | 2 |
|---|
| Amortization of debt discounts | - | - | - | 70,629 |
|---|
| Accounts payable | 117,120 | 16,370 | -12,360 | 15,259 |
|---|
| Accrued interest payable on notes payable | - | 154,660 | 175,392 | - |
|---|
| Net Cash Used by Operating Activities | -249,481 | -556,745 | -602,774 | -133,308 |
|---|
| Accounts payable | 117,120 | 16,370 | -12,360 | 15,259 |
|---|
| Accrued interest payable on notes payable | - | - | - | 291,344 |
|---|
| Music Inventory | - | -1,389 | -183 | - |
|---|
| Net Cash Used by Investing Activities | - | -1,739 | -183 | -28,247 |
|---|
| Accrued consulting fees | - | - | - | 219,700 |
|---|
| Net Cash Used by Operating Activities | -249,481 | -556,745 | -602,774 | -133,308 |
|---|
| Payments from loans receivable, related party | - | - | - | 28,247 |
|---|
| Bank overdraft | 987 | - | 1,140 | 46 |
|---|
| Proceeds from sale of common stock | - | 320,400 | - | - |
|---|
| Proceeds from notes payable | 15,000 | 401,250 | 864,820 | 155,935 |
|---|
| Repayments on notes payable | - | -164,721 | -233,696 | - |
|---|
| Repayments of notes payable to related parties | - | - | -59,349 | - |
|---|
| Net proceeds from notes payable to related parties | - | - | 25,300 | - |
|---|
| Net Cash Provided by Financing Activities | 222,970 | 556,929 | 598,215 | 161,202 |
|---|
| Net Cash Used by Investing Activities | - | -1,739 | -183 | -28,247 |
|---|
| Bank overdraft | 987 | - | 1,140 | 46 |
|---|
| Proceeds from sale of common stock | - | 320,400 | - | - |
|---|
| Proceeds from notes payable | 15,000 | 401,250 | 864,820 | 155,935 |
|---|
| Repayments on notes payable | - | -164,721 | -233,696 | - |
|---|
| Repayments of notes payable to related parties | - | - | -59,349 | - |
|---|
| Net proceeds from notes payable to related parties | - | - | 25,300 | - |
|---|
| Net Cash Provided by Financing Activities | 222,970 | 556,929 | 598,215 | 161,202 |
|---|
| Bank overdraft | 987 | - | 1,140 | 46 |
|---|
| Proceeds from notes payable | 15,000 | 401,250 | 864,820 | 155,935 |
|---|
| Repayments of notes payable to related parties | - | - | - | 29,500 |
|---|
| Proceeds from notes payable to related parties | 6,983 | - | - | 34,721 |
|---|
| Net Cash Provided by Financing Activities | 222,970 | 556,929 | 598,215 | 161,202 |
|---|
| NET DECREASE IN CASH AND CASH EQUIVALENTS | -26,511 | -1,555 | -4,742 | - |
|---|
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS | - | - | - | -353 |
|---|
| CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD | - | 6,297 | 4,742 | - |
|---|
| Interest | - | - | - | - |
|---|
| Income taxes | - | - | - | - |
|---|
| Issuance of stock and promissory note for investment in acquisition | - | - | - | 6 |
|---|
| Conversion of debt and accrued interest into common stock | - | 78,315 | 834,056 | - |
|---|
| Initial derivative liability charged to debt discounts | - | - | - | 61,100 |
|---|
| Common stock issued for merger with Global Nutrition Experience, Inc. | - | 19,300 | - | - |
|---|
| Conversion of debt and accrued interest into common stock | - | - | - | 147,507 |
|---|